The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 93,759 | 3,720,582 | SH | SOLE | 3,720,582 | 0 | 0 | ||
| ADICET BIO INC | COM | 007002108 | 13,080 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ALIGOS THERAPEUTICS INC | COM | 01626L105 | 9,286 | 408,377 | SH | SOLE | 408,377 | 0 | 0 | ||
| ALTIMMUNE INC | COM | 02155H200 | 49,455 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| APTOSE BIOSCIENCES INC | COM | 03835T200 | 9,592 | 1,605,400 | SH | SOLE | 1,605,400 | 0 | 0 | ||
| ATHIRA PHARMA INC | COM | 04746L104 | 31,126 | 1,691,623 | SH | SOLE | 1,691,623 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 5,560 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC | COM | 15117B202 | 25,557 | 1,240,610 | SH | SOLE | 1,240,610 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 9,560 | 1,088,817 | SH | SOLE | 1,088,817 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICAL | COM | 210373106 | 93,955 | 4,016,873 | SH | SOLE | 4,016,873 | 0 | 0 | ||
| CULLINAN MANAGEMENT INC | COM | 230031106 | 49,010 | 1,176,145 | SH | SOLE | 1,176,145 | 0 | 0 | ||
| ESSA PHARMA INC | COM | 29668H708 | 18,178 | 625,754 | SH | SOLE | 625,754 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM | 30233G209 | 7,112 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 172,176 | 6,865,076 | SH | SOLE | 6,865,076 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 22,915 | 372,306 | SH | SOLE | 372,306 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 45,899 | 1,473,014 | SH | SOLE | 1,473,014 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 16,255 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 40,895 | 2,641,809 | SH | SOLE | 2,641,809 | 0 | 0 | ||
| METACRINE INC | COM | 59101E103 | 4,216 | 680,000 | SH | SOLE | 680,000 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 50,971 | 1,536,193 | SH | SOLE | 1,536,193 | 0 | 0 | ||
| PHARVARIS BV | COM | N69605108 | 25,335 | 902,882 | SH | SOLE | 902,882 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 30,041 | 853,206 | SH | SOLE | 853,206 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 3,709 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 13,232 | 591,782 | SH | SOLE | 591,782 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM | 877619106 | 2,449 | 120,649 | SH | SOLE | 120,649 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 43,390 | 4,040,000 | SH | SOLE | 4,040,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 326 | 19,495 | SH | SOLE | 19,495 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H202 | 34,725 | 16,302,596 | SH | SOLE | 16,302,596 | 0 | 0 | ||